GDF15 anticorps (N-Term)
Aperçu rapide pour GDF15 anticorps (N-Term) (ABIN5540380)
Antigène
Voir toutes GDF15 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 30-194, N-Term
-
Specificité
- Recognizes Human Macrophage Inhibitory Cytokine-1 (MIC-1). Other species not tested.
-
Purification
- Affinity Chromatography on Protein G
-
Immunogène
- Genetic immunisation with cDNA encoding amino acids 30-194 (N-term) of MIC-1 proprotein.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Cell based ELISA with intakt, transiently transfected cells: 1/200-1/400. Flow Cytometry: 1.2 μg/10 6 cells.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered saline, pH 7.2 without preservatives
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Date de péremption
- 12 months
-
-
- GDF15 (Growth Differentiation Factor 15 (GDF15))
-
Autre désignation
- gdf15
-
Sujet
- Macrophage inhibitory cytokine-1 (MIC-1) is a member of the transforming growth factor-ß superfamily that regulates a wide variety of physiological processes involved in tissue differentiation and maintenance (1). MIC-1 is synthesized as a 62- kDa intracellular protein, which, after cleavage by a furin like protease, is secreted as a 25- kDa disulphide-linked dimeric protein. Expression of MIC-1 results in inhibition of macrophage activation, regulated by the p53 pathway, in response to pro-inflammatory monokines (1,2). MIC-1 is involved in tumour pathogenesis and its measurement can be used as a clinical tool for the diagnosis of a wide range of cancers. It could be a useful marker for aggressive prostate cancer while MIC-1 is upregulated in advanced and more aggressive prostatic tumours (3).
-
UniProt
- Q99988
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-